8-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.
| Image |  |
|---|---|
| Description | scientific article published on 7 February 2018 |
| Author/s | |
| Publication date | February 8, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |